How has Braze, Inc.'s deferred compensation liability (non-current) changed year-over-year?

Braze, Inc.'s deferred compensation liability (non-current) decreased by 21.4% year-over-year, from $1.4M to $1.1M.

Braze, Inc. BRZE Deferred Compensation Liability (Non-Current)

Deferred Compensation Liability (Non-Current) at other companies

Lantheus HoldingsLNTH

$1.75M+192%

PACS GroupPACS

$11.3M+44.9%

Healthcare Services GroupHCSG

$52.93M+13.2%

CBIZCBZ

$181.52M+12.0%

HWK

HawkinsHWKN

$14.85M+13.1%

Merit Medical SystemsMMSI

$17.37M-6.7%

Other financials

Income statement

See full

Revenue$211.0M+30.2%

Gross profit$138.7M+24.7%

Operating income-$27.5M+31.6%

Net income-$26.6M+25.7%

EPS (diluted)-$0.24+29.4%

Balance sheet

See full

Cash & equivalents$149.3M-35.7%

Total debt$81.5M-6.7%

Total equity$581.7M+22.6%

Total assets$1.1B+22.7%

Cash flow

See full

Operating cash flow$28.1M+16.5%

CapEx$108.0K-50.2%

Free cash flow$28.0M+17.1%

Valuation

See full

Market cap$2.17B-21.2%

Enterprise value$2.1B-19.7%

P/S2.8×-1.7×

Profitability

See full

Gross margin66.5%-3.0pp

Operating margin-16.8%-2.2pp

Net margin-15.5%-1.1pp

FCF margin8.4%—

Returns & leverage

See full

Return on equity-23.1%+0.3pp

Debt / equity0.1×0.0×

Current ratio1.2×-0.7×

Where this comes from

Reported directly by Braze, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.

The official record: Braze, Inc.’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Braze, Inc.'s deferred compensation liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Braze, Inc.'s deferred compensation liability (non-current)?: Braze, Inc. (BRZE) reported deferred compensation liability (non-current) of $1.1M in Q1 2026.
How has Braze, Inc.'s deferred compensation liability (non-current) changed year-over-year?: Braze, Inc.'s deferred compensation liability (non-current) decreased by 21.4% year-over-year, from $1.4M to $1.1M.